Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsCancer stem cells in basic science and in translational oncology: can we translate into clinical application?Survival regulation of leukemia stem cellsFirst-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patientsSingle-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryHeterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaIdentification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors.DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia.Cancer stem cells in haematological malignancies.DPPIV/CD26: a tumor suppressor or a marker of malignancy?Expression of CD25 on leukemic stem cells in BCR-ABL1+ CML: Potential diagnostic value and functional implications.Mechanisms of tumor cell resistance to the current targeted-therapy agents.Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects.Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.Stem cell quest.Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationCancer stem cell surface markers on normal stem cells.Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib.Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI.Aberrant activation of CaMKIIγ accelerates chronic myeloid leukemia blast crisis.Monitoring of leukemia stem cells in chronic myeloid leukemia patients.ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.Suppression of CD26 inhibits growth and metastasis of pancreatic cancer.Targeting Leukemia Stem Cells in the Bone Marrow Niche.Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib.CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells.IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome.
P2860
Q26744536-BA33F145-BB8D-46DD-85F8-24B5545A54B1Q26778929-DC50D7DE-DA2E-4049-913B-497E57FE23B9Q28081844-5F8C1607-A5E7-497C-81FE-3148904A07F7Q28271278-C7231D4C-692C-47DB-8916-3D303D0D6EE6Q33639709-F3FDA919-5364-4FF5-A0D4-09E1BB8264C1Q33820371-2E4C379A-6F94-41C2-A98C-D1387550C853Q33834587-654DB02D-65CE-4636-89E6-3340BDFEBA49Q35183982-5A2979C9-F57D-4C62-8EA3-DCB4A591E2D8Q35634865-C7308E3F-E0E5-4563-904A-8FE41A967F3DQ36165598-5205B712-7EC2-417C-A99D-37F11CC56443Q36210636-CDA94043-1122-49FE-A0DF-2609B4BC6AD2Q36755221-002D5C1F-1510-4A54-ABA2-4365CF375C9CQ36957067-312954CA-8CFD-4A36-8F24-308025C84E37Q37629012-DC8E6015-E702-4AA2-9137-C02ED76F8FF9Q38265115-30462007-7087-423E-8DE4-3401F4A04467Q38359714-8ECD12A5-EC49-4A7B-902B-91B2CEB840E6Q38760903-E89000F7-D2A1-42B3-B516-5B5BE8034FA2Q38812117-170451EB-4EB1-49E1-9485-C11CAC234842Q38828353-A7111CF5-9306-47EB-A500-E95B48676384Q38866390-1CAED1FA-46B3-4D84-B0C9-84D25944156EQ39170884-0989D7F9-B851-4F92-B7E6-7C11CE650B96Q39795335-D5242BA7-F7BA-450F-9BBD-8D5351A1EAB0Q40075528-D1E9EC57-2D85-4FAB-8841-B3922E3483B2Q40096054-EDF9F10E-DFE1-4594-B563-901AF8D04F49Q41610510-17F5F9E8-537D-4CA4-B955-B21AF315752EQ42332008-595B07D4-1D47-4426-AB07-B70E1109659CQ47117016-AF336845-ABEF-4C02-B88E-4CA141C7EE4BQ47136924-FD26EDBF-D8F1-4F0A-A446-29837FE3FCF1Q47592900-DD822FAC-08BE-4DF4-B979-6960E819AD1EQ47627255-A04C9FA7-A487-45FA-9DE6-AB4B78B8B33FQ50044527-55009971-A2CF-4EC0-8ACE-D2A94B1888C8Q50074642-C30CEE96-F580-48FC-8A78-E058A2DDB2F8Q50123249-55D432C0-8BAC-456F-98D5-984E14AA5478Q51415165-EA95B1CA-53A3-48B6-8D36-9310D92BA721Q52375473-CF1FA151-4005-4571-AF41-4811CD65C24EQ52715772-B623BF3F-414F-4BE6-AE3B-442EA4508314Q52735344-D4C03B06-9DD2-446F-B2ED-1938BF2CD8E7Q52846906-E9A5479B-6BED-4F28-9D51-C8E00E741B2DQ53119464-C7D5561D-C1E2-4D80-AB75-77646E43FF59Q53470550-7B17F5DE-C418-4285-9738-DAEC072B2213
P2860
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dipeptidylpeptidase IV (CD26) ...... ) in chronic myeloid leukemia.
@en
Dipeptidylpeptidase IV
@nl
type
label
Dipeptidylpeptidase IV (CD26) ...... ) in chronic myeloid leukemia.
@en
Dipeptidylpeptidase IV
@nl
prefLabel
Dipeptidylpeptidase IV (CD26) ...... ) in chronic myeloid leukemia.
@en
Dipeptidylpeptidase IV
@nl
P2093
P50
P1433
P1476
Dipeptidylpeptidase IV (CD26) ...... ) in chronic myeloid leukemia.
@en
P2093
Berthold Streubel
Katharina Blatt
Matthias Mayerhofer
Michael Willmann
Peter Valent
Susanne Herndlhofer
Thomas Rülicke
Wolfgang R Sperr
P304
P356
10.1182/BLOOD-2013-10-536078
P407
P50
P577
2014-04-28T00:00:00Z